International Journal of Clinical Pharmacy

, Volume 37, Issue 3, pp 452–456 | Cite as

Evaluation of restricted antibiotic use in a hospital in Romania

  • Patricia Tarcea BizoEmail author
  • Diana Dumitras
  • Adina Popa
Short Research Report


Background Antibiotics are the most frequently used drugs among hospitalised patients. Antimicrobial resistance is a major health issue and therefore antibiotic consumption should be under strict surveillance. Objective To evaluate the use of restricted antibiotics in an academic hospital in Romania. Methods Retrospective evaluation of the use of 11 restricted antibiotics issued based on the antibiotics formularies for the year 2012. Therapeutic guidelines and the summary of product characteristics were used for the evaluation. The appropriateness antibiotics use was verified, according to three main criteria: appropriate indication (type of treatment, localization and type of infection), dose and duration of treatment. Descriptive statistics and multiple logistic regression analysis were performed. Results 664 prescribing formularies were analyzed, of these 319 were from the intensive care unit (48.04 %). The most prescribed antibiotics were vancomycin (171, 25.75 %), imipenem (151, 22.74 %) and meropenem (116, 17.47 %). Overall, 285 prescriptions (42.92 %) were considered inappropriate. Vancomycin, meropenem and imipenem were prescribed inappropriate in 49.71, 46.55 and 44.06 % of such cases. Of the total 285 prescriptions deemed as inappropriate, for 49.82 % the dose was incorrect, 20 % were inadequate in terms of treatment duration and 15.44 % were wrongly indicated. Inappropriate use was significantly higher among empirical prescriptions than the documented ones (69.75 vs. 30.25 %, p < 0.001). Multiple stepwise logistic regression identified that the duration of the treatment was significant for inappropriate antibiotic use (p < 0.05). The risk of inappropriate use in the case of empirical prescriptions is higher than for documented prescriptions (OR 5.78, p < 0.001, CI 3.65–9.15). Conclusions the results suggest the need to intensify the control of the use of restricted antibiotics. The implementation of drug formularies in hospitals and the involvement of the clinical pharmacist may ensure rational antibiotic therapy.


Anti-bacterial agents Drug therapy Drug utilisation review Inappropriate use Order forms Restricted antibiotics Romania 



The authors would like to thank the head of the hospital pharmacy, Ms. Carmen Span for granting us access to the prescription formularies.



Conflicts of interest

None declared.


  1. 1.
    Fishman N. Antimicrobial stewardship. Am J Infect Control. 2006;34(5):55–63.CrossRefGoogle Scholar
  2. 2.
    Erbay A, Bodur H, Akinci E, Colpan A. Evaluation of antibiotic use in intensive care units of a tertiary care hospital in Turkey. J Hosp Infect. 2005;59:53–61.CrossRefPubMedGoogle Scholar
  3. 3.
    Thong M, Shortgen F, Zazempa V, Girou E, Soussy CJ, Brun-Buisson C. Appropriate use of restricted antimicrobial agents in hospitals: the importance of empirical therapy and assisted re-evaluation. J Antimicrob Chemother. 2000;46:501–8.CrossRefGoogle Scholar
  4. 4.
    Erbay A, Bodur H, Colpan A, Cevik MA, Samore MH, Ergonul O. Evaluation of antibiotic use in a hospital with an an antibiotic restriction policy. Int J Antimicrob Agents. 2003;21(4):308–12.CrossRefPubMedGoogle Scholar
  5. 5.
    European Centre for Disease Prevention and Control. Surveillance of antimicrobial consumption in Europe 2010. Accessed 10 Nov 2014.
  6. 6.
    Huttner A, Harbarth S, Carlet J, Cosgrove S, Goossens H, Holmes A, et al. Antimicrobial resistance: a global view from 2013. World healthcare-associated infections forum. Antimicrob Resist Infect Control. 2013;2:31.CrossRefPubMedCentralPubMedGoogle Scholar
  7. 7.
    Gilbert DN, Moellering RC, Eliopoulos GM, Chambers HF, Saag MS, editors. The Sanford guide to antimicrobial therapy. 40th ed. Antimicrobial Therapy Inc.; 2010.Google Scholar
  8. 8.
    National Agency for Medicines and Medical Devices. Accessed at 10 Nov 2014.
  9. 9.
    Gould IM, Jappy B. Trends in hospital antibiotic prescribing after introduction of an antibiotic policy. J Antimicrob Chemother. 1996;38:895–904.CrossRefPubMedGoogle Scholar
  10. 10.
    Arda B, Sipahi OR, Yamazhan T, Tasbakan M, Pulluku H, Tunger A, et al. Short-term effect of antibiotic control policy on the usage patterns and cost of antimicrobials, mortality, nosocomial infection rates and antibacterial resistance. J Infect. 2007;55:41–8.CrossRefPubMedGoogle Scholar
  11. 11.
    Zarb P, Goossens H. European surveillance of antimicrobial consumption (ESAC): value of a point-prevalence survey of antimicrobial use across Europe. Drugs. 2011;71:745–55.CrossRefPubMedGoogle Scholar
  12. 12.
    Mouton JW, Touw DJ, Horrevorts AM, Vinks ATMM. Comparative pharmacokinetics of the carbapenems, clinical implications. Clin Pharmacokinet. 2000;39(3):185–201.CrossRefPubMedGoogle Scholar
  13. 13.
    Montero JG, Guttierez-Pizarraya A, Escoresca-Ortega A, Corcia-Palomo Y, Fernandez-Delgado E, Herrera-Melero I, et al. De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock. Intensive Care Med. 2014;40(1):32–40.CrossRefGoogle Scholar
  14. 14.
    Davey P, Brown E, Charani E, Fenelon L, Gould IM, Holmes A, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2013;19(4):CD003543.Google Scholar
  15. 15.
    Spaulding TJ, Raghu TS. Impact of CPOE usage on medication management process costs and quality outcomes. Inquiry. 2013;50(3):229–47.PubMedGoogle Scholar

Copyright information

© Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie 2015

Authors and Affiliations

  • Patricia Tarcea Bizo
    • 1
    Email author
  • Diana Dumitras
    • 2
  • Adina Popa
    • 1
  1. 1.Universitatea de Medicina si Farmacie Iuliu HatieganuCluj-NapocaRomania
  2. 2.University of Agricultural Science and Veterinary MedicineCluj-NapocaRomania

Personalised recommendations